Medtech financing has been volatile over the past few years, but our review of the month-by-month financings (tallied from ongoing efforts at tracking each and every medtech financing) shows that the trend is decidedly upward. Below illustrates the trend from early March 2009 to December 2012, with the data smoothed by calculating rolling three month averages and a calculate trendline inserted.
Source: Compiled by MedMarket Diligence, LLC
The individual monthly financings are tallied and detailed at link.
For reference, we track medtech fundings by SEC filings, company press releases, brokerage reports and other sources, with the definition of “medtech” as follows:
We view medical technology (medtech) as principally medical devices and equipment, but also all technologies that are directly competitive with or complementary to technologies represented by therapeutic or diagnostic medical devices/equipment.